#category	term ID	term description	observed gene count	background gene count	strength	signal	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0001953	Negative regulation of cell-matrix adhesion	3	36	2.07	1.02	0.0083	9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	NF2,PTEN,CDKN2A
GO Process	GO:0008637	Apoptotic mitochondrial changes	3	58	1.86	0.99	0.0083	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
GO Process	GO:0009895	Negative regulation of catabolic process	5	329	1.33	0.84	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000356150,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,MDM4,FHIT,CDKN2A
GO Process	GO:0030162	Regulation of proteolysis	6	739	1.06	0.71	0.0083	9606.ENSP00000269305,9606.ENSP00000302111,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,MGMT,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0031647	Regulation of protein stability	5	328	1.33	0.84	0.0083	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,MDM4,PTEN,CDKN2A
GO Process	GO:0035556	Intracellular signal transduction	8	1518	0.87	0.6	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,NF2,MDM4,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0040008	Regulation of growth	6	671	1.1	0.73	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000324404,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,TCHP,PTEN,BBC3,CDKN2A
GO Process	GO:0042981	Regulation of apoptotic process	8	1462	0.89	0.61	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,MGMT,NF2,MDM4,PTEN,BBC3,CDKN2A
GO Process	GO:0045926	Negative regulation of growth	5	247	1.45	0.89	0.0083	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,TCHP,PTEN,BBC3,CDKN2A
GO Process	GO:0050821	Protein stabilization	4	215	1.42	0.88	0.0083	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,MDM4,PTEN,CDKN2A
GO Process	GO:0051246	Regulation of protein metabolic process	9	2622	0.68	0.48	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,MGMT,NF2,MDM4,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0051248	Negative regulation of protein metabolic process	7	1038	0.98	0.66	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,NF2,MDM4,PTEN,FHIT,CDKN2A
GO Process	GO:0070228	Regulation of lymphocyte apoptotic process	3	64	1.82	0.99	0.0083	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503	TP53,PTEN,BBC3
GO Process	GO:0070245	Positive regulation of thymocyte apoptotic process	2	5	2.75	1.06	0.0083	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0071456	Cellular response to hypoxia	4	128	1.64	0.95	0.0083	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503	TP53,MDM4,PTEN,BBC3
GO Process	GO:0072331	Signal transduction by p53 class mediator	4	93	1.78	0.98	0.0083	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000404503,9606.ENSP00000418582	TP53,MDM4,BBC3,FHIT
GO Process	GO:0072332	Intrinsic apoptotic signaling pathway by p53 class mediator	3	56	1.88	1.0	0.0083	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418582	TP53,BBC3,FHIT
GO Process	GO:0080135	Regulation of cellular response to stress	6	712	1.07	0.72	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,MGMT,PTEN,BBC3,CDKN2A
GO Process	GO:2000045	Regulation of G1/S transition of mitotic cell cycle	4	164	1.54	0.92	0.0083	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
GO Process	GO:2000106	Regulation of leukocyte apoptotic process	4	95	1.77	0.98	0.0083	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,PTEN,BBC3,CDKN2A
GO Process	GO:2000108	Positive regulation of leukocyte apoptotic process	3	31	2.13	1.03	0.0083	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
GO Process	GO:0071479	Cellular response to ionizing radiation	3	75	1.75	0.91	0.0118	9606.ENSP00000269305,9606.ENSP00000302111,9606.ENSP00000404503	TP53,MGMT,BBC3
GO Process	GO:0048523	Negative regulation of cellular process	11	4736	0.51	0.36	0.0146	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000324404,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,TCHP,NF2,MDM4,PTEN,BBC3,FHIT,CDKN2A,RNF43
GO Process	GO:2000109	Regulation of macrophage apoptotic process	2	10	2.45	0.91	0.0161	9606.ENSP00000361021,9606.ENSP00000418915	PTEN,CDKN2A
GO Process	GO:0009894	Regulation of catabolic process	6	988	0.93	0.57	0.0173	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,MDM4,PTEN,FHIT,CDKN2A
GO Process	GO:0051348	Negative regulation of transferase activity	4	274	1.31	0.73	0.0173	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,PTEN,CDKN2A
GO Process	GO:0006915	Apoptotic process	6	1041	0.91	0.55	0.0196	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,TCHP,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0033554	Cellular response to stress	7	1572	0.8	0.5	0.0196	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,MGMT,MDM4,PTEN,BBC3,CDKN2A
GO Process	GO:1903800	Positive regulation of miRNA maturation	2	12	2.37	0.86	0.0196	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	4	316	1.25	0.66	0.0241	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000418915	TP53,EGFR,MGMT,CDKN2A
GO Process	GO:0000079	Regulation of cyclin-dependent protein serine/threonine kinase activity	3	111	1.58	0.74	0.0242	9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	EGFR,PTEN,CDKN2A
GO Process	GO:0009628	Response to abiotic stimulus	6	1107	0.88	0.52	0.0242	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503	TP53,EGFR,MGMT,MDM4,PTEN,BBC3
GO Process	GO:0042177	Negative regulation of protein catabolic process	3	112	1.58	0.74	0.0242	9606.ENSP00000275493,9606.ENSP00000356150,9606.ENSP00000418582	EGFR,MDM4,FHIT
GO Process	GO:0045596	Negative regulation of cell differentiation	5	685	1.01	0.58	0.0242	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,NF2,PTEN,CDKN2A
GO Process	GO:0051726	Regulation of cell cycle	6	1108	0.88	0.52	0.0242	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,NF2,MDM4,PTEN,CDKN2A
GO Process	GO:0060253	Negative regulation of glial cell proliferation	2	16	2.25	0.81	0.0242	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
GO Process	GO:0071214	Cellular response to abiotic stimulus	4	325	1.24	0.66	0.0242	9606.ENSP00000269305,9606.ENSP00000302111,9606.ENSP00000361021,9606.ENSP00000404503	TP53,MGMT,PTEN,BBC3
GO Process	GO:0090399	Replicative senescence	2	16	2.25	0.81	0.0242	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0008283	Cell population proliferation	5	712	0.99	0.56	0.0263	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000463069	TP53,EGFR,NF2,PTEN,RNF43
GO Process	GO:0008285	Negative regulation of cell population proliferation	5	713	0.99	0.56	0.0263	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,MDM4,PTEN,CDKN2A
GO Process	GO:0030889	Negative regulation of B cell proliferation	2	19	2.17	0.79	0.0263	9606.ENSP00000361021,9606.ENSP00000418915	PTEN,CDKN2A
GO Process	GO:2000269	Regulation of fibroblast apoptotic process	2	19	2.17	0.79	0.0263	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:2001235	Positive regulation of apoptotic signaling pathway	3	130	1.51	0.72	0.0263	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503	TP53,PTEN,BBC3
GO Process	GO:0001836	Release of cytochrome c from mitochondria	2	21	2.13	0.77	0.0292	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0008340	Determination of adult lifespan	2	21	2.13	0.77	0.0292	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:1902108	Regulation of mitochondrial membrane permeability involved in apoptotic process	2	22	2.11	0.76	0.0309	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0050768	Negative regulation of neurogenesis	3	143	1.47	0.67	0.0324	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
GO Process	GO:0048512	Circadian behavior	2	24	2.07	0.73	0.0348	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
GO Process	GO:0010661	Positive regulation of muscle cell apoptotic process	2	25	2.05	0.72	0.0359	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:1904666	Regulation of ubiquitin protein ligase activity	2	26	2.03	0.71	0.0371	9606.ENSP00000361021,9606.ENSP00000418915	PTEN,CDKN2A
GO Process	GO:0001558	Regulation of cell growth	4	428	1.12	0.56	0.0375	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000324404,9606.ENSP00000418915	TP53,EGFR,TCHP,CDKN2A
GO Process	GO:0014009	Glial cell proliferation	2	27	2.02	0.71	0.0375	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
GO Process	GO:0045936	Negative regulation of phosphate metabolic process	4	424	1.12	0.56	0.0375	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,PTEN,CDKN2A
GO Process	GO:0051171	Regulation of nitrogen compound metabolic process	11	5734	0.43	0.29	0.0375	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,MGMT,ZNF420,NF2,MDM4,VENTX,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0090200	Positive regulation of release of cytochrome c from mitochondria	2	27	2.02	0.71	0.0375	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0009314	Response to radiation	4	444	1.1	0.55	0.0389	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000404503	TP53,EGFR,MGMT,BBC3
GO Process	GO:0070231	T cell apoptotic process	2	29	1.99	0.7	0.0389	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:2001022	Positive regulation of response to DNA damage stimulus	3	168	1.4	0.63	0.0389	9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000418915	EGFR,MGMT,CDKN2A
GO Process	GO:0045736	Negative regulation of cyclin-dependent protein serine/threonine kinase activity	2	30	1.97	0.69	0.0400	9606.ENSP00000361021,9606.ENSP00000418915	PTEN,CDKN2A
GO Process	GO:2000058	Regulation of ubiquitin-dependent protein catabolic process	3	173	1.39	0.62	0.0404	9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915	PTEN,FHIT,CDKN2A
GO Process	GO:0080090	Regulation of primary metabolic process	11	5899	0.42	0.28	0.0411	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,MGMT,ZNF420,NF2,MDM4,VENTX,PTEN,BBC3,FHIT,CDKN2A
GO Process	GO:0021543	Pallium development	3	179	1.37	0.6	0.0433	9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021	EGFR,NF2,PTEN
GO Process	GO:0035794	Positive regulation of mitochondrial membrane permeability	2	32	1.94	0.67	0.0433	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0042771	Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2	32	1.94	0.67	0.0433	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0043066	Negative regulation of apoptotic process	5	891	0.9	0.47	0.0436	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000356150,9606.ENSP00000361021	TP53,EGFR,MGMT,MDM4,PTEN
GO Process	GO:0070059	Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	2	34	1.92	0.66	0.0452	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
GO Process	GO:0030308	Negative regulation of cell growth	3	189	1.35	0.59	0.0460	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000418915	TP53,TCHP,CDKN2A
GO Process	GO:0051338	Regulation of transferase activity	5	912	0.89	0.46	0.0460	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,NF2,PTEN,CDKN2A
GO Process	GO:0022408	Negative regulation of cell-cell adhesion	3	194	1.34	0.58	0.0476	9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	NF2,PTEN,CDKN2A
STRING clusters	CL:6999	SWIB/MDM2 domain, and Fermentation	3	5	2.93	2.11	7.29e-05	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000356150	TP53,TCHP,MDM4
STRING clusters	CL:6897	Mixed, incl. G1 Phase, and G0 and Early G1	4	67	1.92	1.67	0.00023	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000356150,9606.ENSP00000418915	TP53,TCHP,MDM4,CDKN2A
KEGG	hsa04115	p53 signaling pathway	5	72	1.99	2.74	5.22e-07	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,MDM4,PTEN,BBC3,CDKN2A
KEGG	hsa05206	MicroRNAs in cancer	5	159	1.65	1.93	1.19e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,MDM4,PTEN,CDKN2A
KEGG	hsa05214	Glioma	4	71	1.9	2.1	1.78e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
KEGG	hsa05218	Melanoma	4	72	1.89	2.09	1.78e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
KEGG	hsa05223	Non-small cell lung cancer	4	68	1.92	2.11	1.78e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,FHIT,CDKN2A
KEGG	hsa05219	Bladder cancer	3	40	2.02	1.75	0.00019	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
KEGG	hsa05225	Hepatocellular carcinoma	4	161	1.54	1.46	0.00021	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
KEGG	hsa05213	Endometrial cancer	3	58	1.86	1.54	0.00042	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa01524	Platinum drug resistance	3	70	1.78	1.45	0.00059	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
KEGG	hsa05200	Pathways in cancer	5	515	1.14	1.0	0.00059	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,PTEN,BBC3,CDKN2A
KEGG	hsa05212	Pancreatic cancer	3	71	1.77	1.44	0.00059	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
KEGG	hsa05230	Central carbon metabolism in cancer	3	68	1.79	1.45	0.00059	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa05210	Colorectal cancer	3	82	1.71	1.39	0.00070	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000404503	TP53,EGFR,BBC3
KEGG	hsa01522	Endocrine resistance	3	94	1.65	1.32	0.00091	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
KEGG	hsa05222	Small cell lung cancer	3	92	1.66	1.32	0.00091	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418582	TP53,PTEN,FHIT
KEGG	hsa05215	Prostate cancer	3	97	1.64	1.31	0.00093	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa04218	Cellular senescence	3	150	1.45	1.04	0.0029	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
KEGG	hsa05224	Breast cancer	3	146	1.46	1.05	0.0029	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	3	210	1.3	0.85	0.0073	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
KEGG	hsa05163	Human cytomegalovirus infection	3	217	1.29	0.83	0.0077	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
KEGG	hsa05220	Chronic myeloid leukemia	2	75	1.57	0.77	0.0213	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	2	77	1.56	0.76	0.0214	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
KEGG	hsa05165	Human papillomavirus infection	3	324	1.11	0.63	0.0214	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa04151	PI3K-Akt signaling pathway	3	349	1.08	0.6	0.0248	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	2	87	1.51	0.73	0.0248	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
KEGG	hsa04071	Sphingolipid signaling pathway	2	116	1.38	0.62	0.0399	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
KEGG	hsa04110	Cell cycle	2	120	1.37	0.61	0.0410	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa04068	FoxO signaling pathway	2	126	1.35	0.6	0.0434	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
KEGG	hsa04210	Apoptosis	2	131	1.33	0.59	0.0452	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
KEGG	hsa05162	Measles	2	137	1.31	0.58	0.0476	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
Reactome	HSA-212436	Generic Transcription Pathway	7	1215	0.91	0.66	0.0046	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000338770,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,ZNF420,MDM4,VENTX,PTEN,CDKN2A
Reactome	HSA-2559583	Cellular Senescence	4	163	1.54	1.01	0.0046	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000418915	TP53,MDM4,VENTX,CDKN2A
Reactome	HSA-2559585	Oncogene Induced Senescence	3	33	2.11	1.15	0.0046	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000418915	TP53,MDM4,CDKN2A
Reactome	HSA-8853884	Transcriptional Regulation by VENTX	3	39	2.03	1.14	0.0046	9606.ENSP00000269305,9606.ENSP00000357556,9606.ENSP00000418915	TP53,VENTX,CDKN2A
Reactome	HSA-2559580	Oxidative Stress Induced Senescence	3	92	1.66	0.88	0.0124	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000418915	TP53,MDM4,CDKN2A
Reactome	HSA-3700989	Transcriptional Regulation by TP53	4	361	1.19	0.62	0.0279	9606.ENSP00000269305,9606.ENSP00000338770,9606.ENSP00000356150,9606.ENSP00000361021	TP53,ZNF420,MDM4,PTEN
Reactome	HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	2	19	2.17	0.78	0.0279	9606.ENSP00000269305,9606.ENSP00000338770	TP53,ZNF420
Reactome	HSA-6804760	Regulation of TP53 Activity through Methylation	2	19	2.17	0.78	0.0279	9606.ENSP00000269305,9606.ENSP00000356150	TP53,MDM4
WikiPathways	WP2261	Glioblastoma signaling pathways	5	82	1.93	2.46	2.26e-06	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,MDM4,PTEN,CDKN2A
WikiPathways	WP5087	Malignant pleural mesothelioma	7	434	1.36	1.68	3.13e-06	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,NF2,MDM4,PTEN,BBC3,CDKN2A
WikiPathways	WP4255	Non-small cell lung cancer	4	72	1.89	1.92	5.16e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418582,9606.ENSP00000418915	TP53,EGFR,FHIT,CDKN2A
WikiPathways	WP4674	Head and neck squamous cell carcinoma	4	72	1.89	1.92	5.16e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
WikiPathways	WP1742	TP53 network	3	19	2.35	2.04	6.80e-05	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
WikiPathways	WP3982	miRNA regulation of p53 pathway in prostate cancer	3	24	2.25	1.92	0.00011	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503	TP53,PTEN,BBC3
WikiPathways	WP710	DNA damage response (only ATM dependent)	4	109	1.71	1.68	0.00011	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,PTEN,BBC3,CDKN2A
WikiPathways	WP2828	Bladder cancer	3	39	2.03	1.66	0.00031	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
WikiPathways	WP1971	Integrated cancer pathway	3	44	1.98	1.6	0.00039	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000404503	TP53,PTEN,BBC3
WikiPathways	WP3611	Photodynamic therapy-induced AP-1 survival signaling	3	50	1.93	1.54	0.00048	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
WikiPathways	WP5300	TROP2 regulatory signaling	3	49	1.94	1.55	0.00048	9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	EGFR,PTEN,CDKN2A
WikiPathways	WP3998	Prader-Willi and Angelman syndrome	3	62	1.83	1.42	0.00079	9606.ENSP00000269305,9606.ENSP00000356150,9606.ENSP00000418915	TP53,MDM4,CDKN2A
WikiPathways	WP4155	Endometrial cancer	3	63	1.83	1.42	0.00079	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
WikiPathways	WP4685	Melanoma	3	68	1.79	1.38	0.00088	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
WikiPathways	WP1772	Apoptosis modulation and signaling	3	89	1.68	1.25	0.0015	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
WikiPathways	WP254	Apoptosis	3	83	1.71	1.26	0.0015	9606.ENSP00000269305,9606.ENSP00000404503,9606.ENSP00000418915	TP53,BBC3,CDKN2A
WikiPathways	WP4263	Pancreatic adenocarcinoma pathway	3	86	1.69	1.25	0.0015	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
WikiPathways	WP4963	p53 transcriptional gene network	3	90	1.67	1.24	0.0015	9606.ENSP00000302111,9606.ENSP00000361021,9606.ENSP00000404503	MGMT,PTEN,BBC3
WikiPathways	WP5098	T-cell activation SARS-CoV-2	3	88	1.68	1.25	0.0015	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
WikiPathways	WP4658	Small cell lung cancer	3	95	1.65	1.22	0.0016	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418582	TP53,PTEN,FHIT
WikiPathways	WP5322	CKAP4 signaling pathway map	3	114	1.57	1.11	0.0026	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
WikiPathways	WP4300	Extracellular vesicles in the crosstalk of cardiac cells	2	19	2.17	1.21	0.0035	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
WikiPathways	WP4925	Unfolded protein response	2	24	2.07	1.12	0.0051	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
WikiPathways	WP4262	Breast cancer pathway	3	154	1.44	0.94	0.0055	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
WikiPathways	WP2363	Gastric cancer network 2	2	31	1.96	1.03	0.0076	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
WikiPathways	WP2516	ATM signaling pathway	2	40	1.85	0.92	0.0119	9606.ENSP00000269305,9606.ENSP00000356150	TP53,MDM4
WikiPathways	WP3286	Copper homeostasis	2	51	1.74	0.82	0.0183	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	2	55	1.71	0.8	0.0204	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	2	65	1.64	0.74	0.0264	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
WikiPathways	WP45	G1 to S cell cycle control	2	64	1.64	0.74	0.0264	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP3303	RAC1/PAK1/p38/MMP2 pathway	2	68	1.62	0.73	0.0277	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
WikiPathways	WP707	DNA damage response	2	69	1.61	0.73	0.0277	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
WikiPathways	WP1530	miRNA regulation of DNA damage response	2	71	1.6	0.72	0.0283	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
WikiPathways	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	2	72	1.59	0.72	0.0283	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
WikiPathways	WP4949	16p11.2 proximal deletion syndrome	2	74	1.58	0.71	0.0289	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
WikiPathways	WP4018	Clear cell renal cell carcinoma pathways	2	82	1.54	0.67	0.0343	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
WikiPathways	WP4172	PI3K-Akt signaling pathway	3	336	1.1	0.57	0.0343	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
WikiPathways	WP4806	EGFR tyrosine kinase inhibitor resistance	2	83	1.53	0.67	0.0343	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
WikiPathways	WP138	Androgen receptor signaling pathway	2	90	1.5	0.65	0.0370	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
WikiPathways	WP673	ErbB signaling pathway	2	89	1.5	0.66	0.0370	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
WikiPathways	WP4540	Hippo signaling regulation pathways	2	98	1.46	0.62	0.0424	9606.ENSP00000275493,9606.ENSP00000344666	EGFR,NF2
Monarch	HP:0002861	Melanoma	4	61	1.97	1.37	0.0013	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,PTEN,CDKN2A,RNF43
Monarch	HP:0100013	Neoplasm of the breast	4	64	1.94	1.36	0.0013	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,PTEN,CDKN2A,RNF43
Monarch	HP:0012125	Prostate cancer	3	18	2.37	1.41	0.0015	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0200063	Colorectal polyposis	3	22	2.28	1.4	0.0015	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0011792	Neoplasm by histology	5	275	1.41	1.09	0.0018	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,NF2,PTEN,CDKN2A,RNF43
Monarch	HP:0004375	Neoplasm of the nervous system	4	142	1.6	1.07	0.0037	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000463069	TP53,NF2,PTEN,RNF43
Monarch	HP:0100242	Sarcoma	4	144	1.59	1.07	0.0037	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,PTEN,CDKN2A
Monarch	HP:0100526	Neoplasm of the lung	3	43	1.99	1.17	0.0037	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
Monarch	HP:0100012	Neoplasm of the eye	3	45	1.97	1.16	0.0039	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	EFO:0004842	Eosinophil count	6	734	1.06	0.76	0.0047	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000338770,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000418915	TP53,TCHP,ZNF420,MDM4,PTEN,CDKN2A
Monarch	HP:0002894	Neoplasm of the pancreas	3	52	1.91	1.11	0.0047	9606.ENSP00000269305,9606.ENSP00000418915,9606.ENSP00000463069	TP53,CDKN2A,RNF43
Monarch	HP:0003002	Breast carcinoma	3	54	1.89	1.11	0.0047	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0008069	Neoplasm of the skin	4	175	1.51	1.0	0.0047	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,NF2,PTEN,CDKN2A
Monarch	HP:0011793	Neoplasm by anatomical site	6	732	1.06	0.76	0.0047	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,NF2,PTEN,CDKN2A,RNF43
Monarch	HP:0100615	Ovarian neoplasm	3	52	1.91	1.11	0.0047	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0100008	Schwannoma	2	6	2.67	1.13	0.0061	9606.ENSP00000344666,9606.ENSP00000463069	NF2,RNF43
Monarch	HP:0007378	Neoplasm of the gastrointestinal tract	4	221	1.41	0.9	0.0068	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,PTEN,CDKN2A,RNF43
Monarch	EFO:0007988	Myeloid white cell count	7	1390	0.85	0.58	0.0085	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000338770,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,TCHP,ZNF420,MDM4,PTEN,BBC3,CDKN2A
Monarch	EFO:0004308	Leukocyte count	8	2057	0.74	0.51	0.0096	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000324404,9606.ENSP00000338770,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418915	TP53,EGFR,TCHP,ZNF420,MDM4,PTEN,BBC3,CDKN2A
Monarch	HP:0100835	Benign neoplasm of the central nervous system	3	78	1.73	0.94	0.0096	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	EFO:0004528	Mean corpuscular hemoglobin concentration	5	546	1.11	0.71	0.0104	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,PTEN,CDKN2A,RNF43
Monarch	EFO:0000272	Astrocytoma	2	11	2.41	0.96	0.0128	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
Monarch	EFO:0000326	Central nervous system cancer	2	11	2.41	0.96	0.0128	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
Monarch	EFO:0000519	Glioblastoma multiforme	2	11	2.41	0.96	0.0128	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
Monarch	HP:0002665	Lymphoma	3	90	1.67	0.88	0.0128	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0012732	Anorectal anomaly	4	274	1.31	0.77	0.0128	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000463069	TP53,EGFR,PTEN,RNF43
Monarch	HP:0002888	Ependymoma	2	13	2.34	0.95	0.0130	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
Monarch	HP:0030078	Lung adenocarcinoma	2	13	2.34	0.95	0.0130	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
Monarch	HP:0030448	Soft tissue sarcoma	3	104	1.61	0.85	0.0135	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	HP:0100641	Neoplasm of the adrenal cortex	2	14	2.3	0.94	0.0136	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
Monarch	HP:0010786	Urinary tract neoplasm	3	110	1.58	0.83	0.0149	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000463069	TP53,PTEN,RNF43
Monarch	HP:0100568	Neoplasm of the endocrine system	3	114	1.57	0.82	0.0157	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	HP:0006725	Pancreatic adenocarcinoma	2	18	2.19	0.87	0.0183	9606.ENSP00000418915,9606.ENSP00000463069	CDKN2A,RNF43
Monarch	HP:0009592	Astrocytoma	2	18	2.19	0.87	0.0183	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
Monarch	HP:0009594	Retinal hamartoma	2	18	2.19	0.87	0.0183	9606.ENSP00000344666,9606.ENSP00000361021	NF2,PTEN
Monarch	HP:0012189	Hodgkin lymphoma	2	20	2.15	0.84	0.0208	9606.ENSP00000269305,9606.ENSP00000463069	TP53,RNF43
Monarch	HP:0010788	Testicular neoplasm	2	26	2.03	0.74	0.0329	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
Monarch	HP:0025085	Bloody diarrhea	2	27	2.02	0.73	0.0333	9606.ENSP00000275493,9606.ENSP00000361021	EGFR,PTEN
Monarch	HP:0012718	Morphological abnormality of the gastrointestinal tract	5	845	0.92	0.5	0.0366	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,PTEN,CDKN2A,RNF43
Monarch	HP:0025033	Abnormality of digestive system morphology	5	849	0.92	0.5	0.0369	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,PTEN,CDKN2A,RNF43
Monarch	HP:0000834	Abnormality of the adrenal glands	3	169	1.4	0.64	0.0370	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	HP:0002862	Bladder carcinoma	2	30	1.97	0.71	0.0370	9606.ENSP00000361021,9606.ENSP00000463069	PTEN,RNF43
Monarch	HP:0004374	Hemiplegia/hemiparesis	3	170	1.39	0.64	0.0370	9606.ENSP00000269305,9606.ENSP00000344666,9606.ENSP00000361021	TP53,NF2,PTEN
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	6	1384	0.79	0.44	0.0370	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,NF2,PTEN,CDKN2A,RNF43
Monarch	EFO:0004526	Mean corpuscular volume	5	875	0.91	0.49	0.0382	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,PTEN,CDKN2A,RNF43
Monarch	HP:0002858	Meningioma	2	33	1.93	0.69	0.0404	9606.ENSP00000344666,9606.ENSP00000361021	NF2,PTEN
Monarch	EFO:0007985	Platelet crit	4	477	1.07	0.53	0.0419	9606.ENSP00000275493,9606.ENSP00000338770,9606.ENSP00000361021,9606.ENSP00000418915	EGFR,ZNF420,PTEN,CDKN2A
Monarch	HP:0100728	Germ cell neoplasia	2	35	1.91	0.67	0.0441	9606.ENSP00000269305,9606.ENSP00000463069	TP53,RNF43
DISEASES	DOID:3070	Malignant glioma	6	40	2.32	4.07	1.57e-09	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,MGMT,NF2,PTEN,CDKN2A
DISEASES	DOID:3068	Glioblastoma multiforme	5	14	2.7	4.27	2.15e-09	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,MGMT,PTEN,CDKN2A
DISEASES	DOID:3093	Nervous system cancer	7	130	1.88	3.32	3.39e-09	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000324404,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,MGMT,TCHP,NF2,PTEN,CDKN2A
DISEASES	DOID:0050687	Cell type cancer	9	451	1.45	2.34	3.94e-09	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,NF2,C17orf97,PTEN,FHIT,CDKN2A,RNF43
DISEASES	DOID:0050686	Organ system cancer	10	757	1.27	1.88	5.00e-09	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000324404,9606.ENSP00000344666,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,TCHP,NF2,C17orf97,PTEN,FHIT,CDKN2A,RNF43
DISEASES	DOID:299	Adenocarcinoma	6	119	1.85	2.84	8.47e-08	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,C17orf97,PTEN,CDKN2A,RNF43
DISEASES	DOID:5520	Head and neck squamous cell carcinoma	4	11	2.71	3.48	9.94e-08	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
DISEASES	DOID:1319	Brain cancer	5	53	2.12	3.11	1.19e-07	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000418915	TP53,EGFR,MGMT,NF2,CDKN2A
DISEASES	DOID:305	Carcinoma	7	307	1.51	2.15	2.33e-07	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,C17orf97,PTEN,FHIT,CDKN2A,RNF43
DISEASES	DOID:3119	Gastrointestinal system cancer	6	161	1.72	2.5	2.75e-07	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,C17orf97,PTEN,CDKN2A,RNF43
DISEASES	DOID:4947	Cholangiocarcinoma	4	40	2.15	2.45	5.74e-06	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000463069	TP53,EGFR,PTEN,RNF43
DISEASES	DOID:5672	Large intestine cancer	4	44	2.11	2.4	6.66e-06	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000418915	TP53,EGFR,C17orf97,CDKN2A
DISEASES	DOID:4074	Pancreatic adenocarcinoma	3	9	2.67	2.47	1.20e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:0060108	Brain glioma	3	10	2.63	2.42	1.49e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:1612	Breast cancer	4	62	1.96	2.12	1.90e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
DISEASES	DOID:0060119	Pharynx cancer	3	12	2.55	2.33	2.07e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:1324	Lung cancer	4	64	1.94	2.1	2.07e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021,9606.ENSP00000418915	TP53,EGFR,PTEN,CDKN2A
DISEASES	DOID:3910	Lung adenocarcinoma	3	13	2.51	2.29	2.43e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:768	Retinoblastoma	3	16	2.42	2.19	3.54e-05	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000418915	TP53,TCHP,CDKN2A
DISEASES	DOID:1795	Tumor of exocrine pancreas	3	17	2.39	2.17	3.80e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:3996	Urinary system cancer	4	89	1.8	1.86	4.90e-05	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915	TP53,PTEN,FHIT,CDKN2A
DISEASES	DOID:0060085	Organ system benign neoplasm	5	237	1.47	1.57	5.23e-05	9606.ENSP00000269305,9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418915	TP53,MGMT,NF2,PTEN,CDKN2A
DISEASES	DOID:120	Female reproductive organ cancer	4	100	1.75	1.77	7.17e-05	9606.ENSP00000269305,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418915	TP53,C17orf97,PTEN,CDKN2A
DISEASES	DOID:3908	Lung non-small cell carcinoma	3	26	2.21	1.93	0.00010	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:3459	Breast carcinoma	3	29	2.16	1.87	0.00013	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
DISEASES	DOID:0060090	Central nervous system benign neoplasm	3	34	2.09	1.77	0.00019	9606.ENSP00000302111,9606.ENSP00000344666,9606.ENSP00000361021	MGMT,NF2,PTEN
DISEASES	DOID:289	Endometriosis	3	34	2.09	1.77	0.00019	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
DISEASES	DOID:11166	Obsolete papillomavirus infectious disease	2	2	3.15	1.87	0.00023	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:11054	Urinary bladder cancer	3	38	2.05	1.71	0.00024	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
DISEASES	DOID:3451	Skin carcinoma	3	39	2.03	1.69	0.00026	9606.ENSP00000269305,9606.ENSP00000353245,9606.ENSP00000418915	TP53,C17orf97,CDKN2A
DISEASES	DOID:3907	Lung squamous cell carcinoma	2	3	2.97	1.76	0.00036	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
DISEASES	DOID:363	Uterine cancer	3	46	1.96	1.59	0.00039	9606.ENSP00000269305,9606.ENSP00000361021,9606.ENSP00000418915	TP53,PTEN,CDKN2A
DISEASES	DOID:1294	Vulva carcinoma	2	5	2.75	1.61	0.00068	9606.ENSP00000353245,9606.ENSP00000418915	C17orf97,CDKN2A
DISEASES	DOID:3012	Li-Fraumeni syndrome	2	6	2.67	1.56	0.00086	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:3498	Pancreatic ductal adenocarcinoma	2	6	2.67	1.56	0.00086	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:4908	Anal carcinoma	2	6	2.67	1.56	0.00086	9606.ENSP00000353245,9606.ENSP00000418915	C17orf97,CDKN2A
DISEASES	DOID:8557	Oropharynx cancer	2	7	2.6	1.52	0.0010	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:0080199	Colorectal carcinoma	2	9	2.5	1.42	0.0015	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
DISEASES	DOID:2871	Endometrial carcinoma	2	9	2.5	1.42	0.0015	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
DISEASES	DOID:2893	Cervix carcinoma	2	9	2.5	1.42	0.0015	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:9561	Nasopharyngeal disease	2	9	2.5	1.42	0.0015	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:0050621	Respiratory system benign neoplasm	2	12	2.37	1.33	0.0022	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:8923	Skin melanoma	2	12	2.37	1.33	0.0022	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:8719	In situ carcinoma	2	13	2.34	1.3	0.0025	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
DISEASES	DOID:0060095	Uterine benign neoplasm	2	14	2.3	1.27	0.0028	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
DISEASES	DOID:786	Laryngeal disease	2	14	2.3	1.27	0.0028	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:4001	Ovarian carcinoma	2	16	2.25	1.23	0.0034	9606.ENSP00000269305,9606.ENSP00000353245	TP53,C17orf97
DISEASES	DOID:219	Colon cancer	2	17	2.22	1.21	0.0037	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
DISEASES	DOID:8618	Oral cavity cancer	2	18	2.19	1.18	0.0041	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:4706	Infratentorial cancer	2	19	2.17	1.17	0.0044	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
DISEASES	DOID:28	Endocrine system disease	4	398	1.15	0.79	0.0063	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000418915	TP53,EGFR,C17orf97,CDKN2A
DISEASES	DOID:1192	Peripheral nervous system neoplasm	2	26	2.03	1.05	0.0073	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
DISEASES	DOID:2513	Basal cell carcinoma	2	27	2.02	1.03	0.0078	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:0060084	Cell type benign neoplasm	3	173	1.39	0.84	0.0097	9606.ENSP00000269305,9606.ENSP00000302111,9606.ENSP00000344666	TP53,MGMT,NF2
DISEASES	DOID:10534	Stomach cancer	2	31	1.96	0.97	0.0099	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
DISEASES	DOID:7	Disease of anatomical entity	10	4798	0.47	0.35	0.0108	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000324404,9606.ENSP00000344666,9606.ENSP00000353245,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,TCHP,NF2,C17orf97,PTEN,FHIT,CDKN2A,RNF43
DISEASES	DOID:184	Bone cancer	2	36	1.89	0.92	0.0127	9606.ENSP00000269305,9606.ENSP00000344666	TP53,NF2
DISEASES	DOID:319	Spinal cord disease	2	38	1.87	0.89	0.0140	9606.ENSP00000302111,9606.ENSP00000344666	MGMT,NF2
DISEASES	DOID:37	Skin disease	4	518	1.04	0.64	0.0152	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000353245,9606.ENSP00000418915	TP53,EGFR,C17orf97,CDKN2A
DISEASES	DOID:263	Kidney cancer	2	51	1.74	0.78	0.0232	9606.ENSP00000269305,9606.ENSP00000418582	TP53,FHIT
DISEASES	DOID:3856	Male reproductive organ cancer	2	75	1.57	0.62	0.0474	9606.ENSP00000361021,9606.ENSP00000418915	PTEN,CDKN2A
TISSUES	BTO:0002036	U-87MG cell	3	4	3.02	2.36	2.42e-05	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111	TP53,EGFR,MGMT
TISSUES	BTO:0000458	WI-38 cell	2	2	3.15	1.47	0.0014	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0001583	T-98G cell	2	2	3.15	1.47	0.0014	9606.ENSP00000269305,9606.ENSP00000302111	TP53,MGMT
TISSUES	BTO:0001740	Hypopharynx	2	2	3.15	1.47	0.0014	9606.ENSP00000275493,9606.ENSP00000418915	EGFR,CDKN2A
TISSUES	BTO:0005257	Oropharynx	2	2	3.15	1.47	0.0014	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0005838	Head and neck cancer cell	2	4	2.85	1.39	0.0019	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
TISSUES	BTO:0001130	Prostate gland cancer cell	2	7	2.6	1.21	0.0041	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
TISSUES	BTO:0001049	Pharynx	3	75	1.75	1.08	0.0046	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
TISSUES	BTO:0000815	MDA-MB-231 cell	2	9	2.5	1.17	0.0048	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
TISSUES	BTO:0000353	Lung cell line	3	85	1.7	1.04	0.0052	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915	TP53,EGFR,CDKN2A
TISSUES	BTO:0000093	MCF-7 cell	2	11	2.41	1.12	0.0059	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
TISSUES	BTO:0004078	Non-small cell lung adenocarcinoma cell line	2	12	2.37	1.1	0.0064	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
TISSUES	BTO:0000711	Glioma cell line	2	21	2.13	0.91	0.0150	9606.ENSP00000269305,9606.ENSP00000302111	TP53,MGMT
TISSUES	BTO:0001616	Colorectal cancer cell line	2	34	1.92	0.73	0.0321	9606.ENSP00000269305,9606.ENSP00000275493	TP53,EGFR
TISSUES	BTO:0001090	Mouth	4	532	1.02	0.53	0.0377	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,CDKN2A,RNF43
COMPARTMENTS	GOCC:0038201	TOR complex	3	24	2.25	1.35	0.0019	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000361021	TP53,EGFR,PTEN
COMPARTMENTS	GOCC:0009341	Beta-galactosidase complex	2	3	2.97	1.16	0.0054	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
COMPARTMENTS	GOCC:1990455	PTEN phosphatase complex	2	5	2.75	1.09	0.0075	9606.ENSP00000269305,9606.ENSP00000361021	TP53,PTEN
COMPARTMENTS	GOCC:0005634	Nucleus	11	4787	0.51	0.36	0.0139	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,ZNF420,NF2,MDM4,VENTX,PTEN,FHIT,CDKN2A,RNF43
COMPARTMENTS	GOCC:0043231	Intracellular membrane-bounded organelle	13	8162	0.35	0.26	0.0352	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000324404,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000404503,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,TCHP,ZNF420,NF2,MDM4,VENTX,PTEN,BBC3,FHIT,CDKN2A,RNF43
COMPARTMENTS	GOCC:0097136	Bcl-2 family protein complex	2	23	2.09	0.67	0.0458	9606.ENSP00000269305,9606.ENSP00000404503	TP53,BBC3
UniProt Keywords	KW-0043	Tumor suppressor	6	177	1.68	2.27	1.12e-06	9606.ENSP00000269305,9606.ENSP00000324404,9606.ENSP00000344666,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915	TP53,TCHP,NF2,PTEN,FHIT,CDKN2A
UniProt Keywords	KW-0435	Li-Fraumeni syndrome	2	3	2.97	1.43	0.0016	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
UniProt Keywords	KW-0539	Nucleus	11	5278	0.47	0.34	0.0166	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000302111,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000357556,9606.ENSP00000361021,9606.ENSP00000418582,9606.ENSP00000418915,9606.ENSP00000463069	TP53,EGFR,MGMT,ZNF420,NF2,MDM4,VENTX,PTEN,FHIT,CDKN2A,RNF43
UniProt Keywords	KW-0832	Ubl conjugation	8	2399	0.67	0.44	0.0166	9606.ENSP00000269305,9606.ENSP00000275493,9606.ENSP00000324404,9606.ENSP00000338770,9606.ENSP00000344666,9606.ENSP00000356150,9606.ENSP00000361021,9606.ENSP00000463069	TP53,EGFR,TCHP,ZNF420,NF2,MDM4,PTEN,RNF43
